Aeon Co., Ltd.
Q1 FY2027 Financial Summary (Consolidated) [Japanese GAAP] (Consolidated) [Listed: TSE]
For the first quarter of FY2027, the consolidated results achieved record high net sales of 2,941,981 million yen, operating income of 75,203 million yen, ordinary income of 63,582 million yen, and net income attributable to owners of the parent of 13,809 million yen. The full-year outlook is net sales of 12,000,000 million yen, operating income of 340,000 million yen, and net income for the period of 73,000 million yen. Segment details include GMS, supermarkets, discount stores, etc. Earnings per share for the quarter, adjusted for the stock split, is 4.99 yen.
Key Figures
- Net Sales: 2,941,981 百万円
- Operating Income: 75,203 百万円
- Ordinary Income: 63,582 百万円
AI要約
Overview of Results
For the first quarter of this term, consolidated results exceeded the previous year's first quarter, with net sales rising 114.6% year on year and substantial increases in operating income and ordinary income. Growth drivers include Health & Wellness, Developer & Entertainment, and the ASEAN market, with a focus on strengthening a high-earnings portfolio across the group. The full-year outlook targets net sales above 12 trillion yen and aims to achieve EBITDA and ROE targets as part of the medium-term plan, emphasizing capital efficiency. The earnings summary provides detailed segment results and initiatives.
Outlook and Capital Allocation
Based on the medium-term management plan 2026-2030, the company will continue to improve profitability and capital efficiency. Through reforms to the food retail earnings structure, business structure reforms, and financial structure optimization, the aim is for EBITDA around 11 trillion yen and ROE of 8.5% or higher by fiscal 2030. Growth drivers include synergy from Health & Wellness integration, expansion in ASEAN markets such as Vietnam, and productivity improvements through digital marketing and DX initiatives.
Segment Revenue Composition
Aeon Co., Ltd.
Company overview · Stock price · Financial data · All IR
